Publications scientifiques

2467 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2021

JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

PREMIER AUTEURVandendorpe B

TITREPsychological and physical impact in women treated for breast cancer: Need for multidisciplinary surveillance and care provision.

ANNÉE2021

JOURNALACS applied materials & interfaces

PREMIER AUTEURMa B

TITREReaction between Graphene Oxide and Intracellular Glutathione Affects Cell Viability and Proliferation.

ANNÉE2021

JOURNALThe oncologist

PREMIER AUTEURBouleuc C

TITREWe need randomised studies to improve our knowledge on nutritional interventions for advanced cancer patients.

ANNÉE2021

JOURNALBMC medical research methodology

PREMIER AUTEURGuilloteau A

TITREImpact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.

ANNÉE2021

JOURNALCancer immunology research

PREMIER AUTEURBernard A

TITREThe tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNA.

ANNÉE2021

JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

PREMIER AUTEURKuntz L

TITRE[Repeated irradiation of brain metastases under stereotactic conditions: A review of the literature].

ANNÉE2021

JOURNALOncology reports

PREMIER AUTEURPflumio C

TITREExpression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.

ANNÉE2021

JOURNALPathogens (Basel, Switzerland)

PREMIER AUTEURPolyak SJ

TITRELiver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure.

ANNÉE2021

JOURNALCancers

PREMIER AUTEURGiraud N

TITREMRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma.

ANNÉE2021

JOURNALCancer gene therapy

PREMIER AUTEURWarda W

TITREOvercoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques